Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines
Source abstract
Abstract
Breast cancer is a major form of cancer, with a high mortality rate in women. It is crucial to achieve more efficient and safe anticancer drugs. Recent developments in medical nanotechnology have resulted in novel advances in cancer drug delivery. Cisplatin, doxorubicin, and 5-fluorouracil are three important anti-cancer drugs which have poor water-solubility. In this study, we used cisplatin, doxorubicin, and 5-fluorouracil-loaded polycaprolactone-polyethylene glycol (PCL-PEG) nanoparticles to improve the stability and solubility of molecules in drug delivery systems. The nanoparticles were prepared by a double emulsion method and characterized with Fourier Transform Infrared (FTIR) spectroscopy and Hydrogen-1 nuclear magnetic resonance ((1)HNMR). Cells were treated with equal concentrations of cisplatin, doxorubicin and 5-fluorouracil-loaded PCL-PEG nanoparticles, and free cisplatin, doxorubicin and 5-fluorouracil. The 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide (MTT) assay confirmed that cisplatin, doxorubicin, and 5-fluorouracil-loaded PCL-PEG nanoparticles enhanced cytotoxicity and drug delivery in T47D and MCF7 breast cancer cells. However, the IC50 value of doxorubicin was lower than the IC50 values of both cisplatin and 5-fluorouracil, where the difference was statistically considered significant (p˂0.05). However, the IC50 value of all drugs on T47D were lower than those on MCF7.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (80)
Show source-provided references
1. Abbasi E · Artif Cells Nanomed Biotechnol · 2014 · 30 · 1
2. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
3. Abbasi E · Crit Rev Microbiol · 2014 · 17 · 110.3109/1040841X.2014.912200 ↗
4. 10.1007/s11033-013-3014-410.1007/s11033-013-3014-4 ↗
5. Akbarzadeh A · Int J Nanomedicine · 2012 · 7 · 511
6. Akbarzadeh A · Nanoscale Res Lett · 2012 · 710.1186/1556-276X-7-144 ↗
7. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
8. 10.1186/1477-3155-10-4610.1186/1477-3155-10-46 ↗
9. Akbarzadeh A · Nanotechnol Sci Appl · 2012 · 5 · 13
10. Alimirzalu S · Asian Pac J Cancer Prev · 2014 · 15 · 4910.7314/APJCP.2014.15.1.49 ↗
11. Alizadeh E · Chem Biol Drug Des · 2014 · 85 · 600
12. Alizadeh E · Artif Cells Nanomed Biotechnol · 2014 · 30 · 1
13. 10.7314/APJCP.2014.15.20.893110.7314/APJCP.2014.15.20.8931 ↗
14. Badrzadeh F · Artif Cells Nanomed Biotechnol · 2014 · 11 · 1
15. 10.1002/med.2014010.1002/med.20140 ↗
16. Barkhordari A · Bio infopublications · 2014
17. Bogdanov A · Neoplasia · 1999 · 1 · 43810.1038/sj.neo.7900044 ↗
18. Chung JH · Artif Cells Nanomed Biotechnol · 2014 · 11 · 1
19. Dadashzadeh K · Asian Pac J Cancer Prev · 2014 · 15 · 888310.7314/APJCP.2014.15.20.8883 ↗
20. 10.1016/j.jconrel.2012.01.04310.1016/j.jconrel.2012.01.043 ↗
21. Daraee H · Artif Cells Nanome Biotechnol · 2014 · 1
22. Daraee H · Artif Cells Nanomed Biotechnol · 2014 · 1
23. Daraee H · Artif Cells Nanomed Biotechnol · 2014 · 1
24. Daraee H · Artif Cells Nanomed Biotechnol · 2014 · 15 · 1
25. 10.4236/jeas.2013.3401310.4236/jeas.2013.34013 ↗
26. Davaran S · Advances in Nanoparticles · 2014 · 3 · 1410.4236/anp.2014.31003 ↗
27. 10.7314/APJCP.2014.15.10.435310.7314/APJCP.2014.15.10.4353 ↗
28. Eatemadi A · Nanoscale Res Lett · 2014 · 9 · 110.1186/1556-276X-9-393 ↗
29. Eatemadi A · Nanoscale Res Lett · 2014 · 9 · 39310.1186/1556-276X-9-393 ↗
30. Eatemadi A · Artif Cells Nanomed Biotechnol · 2014 · 1
31. Eatemadi A · Artif Cells Nanomed Biotechnol · 2014 · 6 · 1
32. Ebrahimi E · Artif Cells Nanomed Biotechnol · 2014 · 11 · 1
33. Ebrahimi E · Artif Cells Nanomed Biotechnol · 2014 · 1
34. Ebrahimnezhad Z · BioImpacts · 2013 · 3 · 67
35. Fallahzadeh S · Antennas and Wireless Propagation Letters, IEEE · 2010 · 9 · 12210.1109/LAWP.2010.2043810 ↗
36. 10.1021/nn900002m10.1021/nn900002m ↗
37. Fekri Aval S · Artif Cells Nanomed Biotechnol · 2014 · 14 · 1
38. 10.2147/IJN.S3360710.2147/IJN.S33607 ↗
39. 10.7314/APJCP.2014.15.17.711310.7314/APJCP.2014.15.17.7113 ↗
40. 10.7314/APJCP.2013.14.11.694910.7314/APJCP.2013.14.11.6949 ↗
41. 10.1016/j.addr.2008.03.01610.1016/j.addr.2008.03.016 ↗
42. Herizchi R · Artif Cells Nanomed Biotechnol · 2014 · 3 · 1
43. 10.1007/s00018-009-0053-z10.1007/s00018-009-0053-z ↗
44. 10.1111/cbdd.1231810.1111/cbdd.12318 ↗
45. 10.1080/1071754080232172710.1080/10717540802321727 ↗
46. Kafshdooz T · Artif Cells Nanomed Biotechnol · 2014 · 3 · 1
47. Karnoosh-Yamchi J · Molecular Biol Rep · 2014 · 41 · 670510.1007/s11033-014-3553-3 ↗
48. Kordi S · Artif Cells Nanomed Biotechnol · 2014 · 1 · 1
49. Kordi S · Artif Cells Nanomed Biotechnol · 2014
50. 10.1186/1556-276X-9-13110.1186/1556-276X-9-131 ↗
51. 10.1016/j.colsurfb.2009.09.00110.1016/j.colsurfb.2009.09.001 ↗
52. 10.1186/1477-3155-9-5510.1186/1477-3155-9-55 ↗
53. Majidi S · Artif Cells Nanomed Biotechnol · 2014 · 1 · 1
54. Mellatyar H · Asian Pac J Cancer Prev · 2014 · 15 · 869310.7314/APJCP.2014.15.20.8693 ↗
55. Misra R · Eur J Pharm Sci · 2010 · 39 · 15210.1016/j.ejps.2009.11.010 ↗
56. Moghimi SM · J Control Release · 2010 · 146 · 17510.1016/j.jconrel.2010.04.003 ↗
57. 10.7314/APJCP.2013.14.11.692510.7314/APJCP.2013.14.11.6925 ↗
58. Nasrabadi HT · Artif Cells Nanomed Biotechnol · 2014 · 9 · 1
59. 10.7314/APJCP.2013.14.11.659510.7314/APJCP.2013.14.11.6595 ↗
60. 10.3109/02652048.2014.94001110.3109/02652048.2014.940011 ↗
61. 10.1186/1556-276X-8-48510.1186/1556-276X-8-485 ↗
62. Pourhassan-Moghaddam M · IET Digital Library · 2014 · 9 · 345
63. Rahimzadeh A · Artif Cells Nanomed Biotechnol · 2014 · 23 · 1
64. 10.4236/soft.2013.2300410.4236/soft.2013.23004 ↗
65. 10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L ↗
66. Sadat TMF · Artif Cells Nanomed Biotechnol · 2014 · 17 · 1
67. Sadat TMF · Asian Pac J Cancer Prev · 2014 · 15 · 51710.7314/APJCP.2014.15.2.517 ↗
68. Seidi K · J AIDS Clin Res · 2014 · 510.4172/2155-6113.1000304 ↗
69. Shafiei A · Mol Biol Rep · 2014
70. Sohrabi N · Artif Cells Nanomed Biotechnol · 2014 · 13 · 1
71. Taheri M · Int J Biosci · 2014 · 4 · 134
72. 10.1007/s11095-006-9132-010.1007/s11095-006-9132-0 ↗
73. Tozihi M · Int J Biosci (IJB) · 2014
74. Valizadeh A · Artif Cells Nanomed Biotechnol · 2014
75. 10.1186/1556-276X-7-48010.1186/1556-276X-7-480 ↗
76. 10.1146/annurev-med-040210-16254410.1146/annurev-med-040210-162544 ↗
77. 10.1016/j.msec.2006.05.02910.1016/j.msec.2006.05.029 ↗
78. 10.1111/cbdd.1248510.1111/cbdd.12485 ↗
79. Zare M · Artif Cells Nanomed Biotechnol · 2014 · 25 · 1
80. 10.7314/APJCP.2014.15.16.658110.7314/APJCP.2014.15.16.6581 ↗